Blog

What is sarcoma and why is it sometimes called the “forgotten cancer?"

Each month, the Cancer Policy Insitute will be profiling advocates who have been engaged in advocacy in their home state, their community, with elected officials, and more. Read on to learn more about our affiliate leaders visits on Capitol Hill this month and their individual experiences with advocacy. If you are interested in learning more about policy, advocacy, and ways to get involved, sign up to be a part of the Grassroots Network!

We mark Men’s Health Month every June to raise awareness of men’s health issues. This year, the month focuses on diabetes. Men are more likely than women to develop diabetes and may face a higher risk for certain types of cancer due to the link between diabetes and cancer.

Back in January, the Trump Administration proposed a new rule that would expand the availability of Association Health Plans (AHPs) that are exempt from regulations like the 10 essential health benefits (EHBs) set by the Patient Protection and Affordable Care Act (ACA or Obamacare). This week, the Trump Administration released a finalized policy to allow loosely affiliated business to band together as AHPs and offer plans that are not held to many important ACA consumer protections.

Today is the final day of the American Society of Clinical Oncology’s annual conference, which is the largest gathering of oncology professionals from around the world.

Throughout the conference, we’ve posted blogs sharing our latest research on gastric cancer and melanoma. Today’s blog is a short post covering our research on patient-clinician communication about eating and nutrition.

Last Friday, you may have seen a post on our blog explaining that we will be sharing three Q-and-A blogs sharing the significance of our latest research abstracts at the American Society of Oncology’s annual conference that will greatly impact people affected by cancer.

Today’s blog covers our latest research on communication between melanoma patients and their health care team.

Below see our second Q-and-A with our President, Linda House, on the topic.

From today through June 5, we will be at the largest gathering of oncology professionals from around the world in Chicago, Illinois.

The American Society of Clinical Oncology’s annual conference is a fantastic opportunity for us to share three exciting new research abstracts that will greatly impact people affected by cancer.

Throughout the conference, we will post a series of short Q-and-A blogs explaining the significance of our findings. Today’s blog covers our latest research on communication between gastric cancer patients and their health care team.

Brain cancer is a life-changing and often lethal illness that warrants our increased attention and resources. Knowledge of the brain tumor experience by a wider portion of the population is an important first step to fighting this disease.

Starting in 2012 the Food and Drug Administration (FDA) began to integrate the patient perspective into the drug development process through their Patient-Focused Drug Development (PFDD) initiative. The patient advocacy community can and should partner with the FDA to ensure that they are measuring the full patient experience in clinical trials to include the physical, social, and emotional impacts of a therapy, and CSC has been working closely with the FDA, and other researchers, to explore ways to do so in a more meaningful way.

With summer just around the corner, your risk of developing skin cancer becomes even higher. While it may be tempting to spend more hours out in the sun, be sure to take necessary measures to protect yourself from harmful rays.

Here are five ways you can protect your skin from the sun this summer.